Synthra develops in vitro cell-free systems to produce recombinant proteins and antibodies faster and cheaper than traditional fermentation. Based in Perth with partnerships through Curtin University and local biotech hubs, targeting European and US markets for orphan drug manufacturing. Recent $2M seed round from AusBiotech syndicate.